Squire Sanders announced today that Adam Colvin has joined the firm as a partner in the Healthcare Practice Group. He will be resident in the firm’s Cincinnati office.
Colvin focuses his practice on regulatory and transactional matters, including fraud and abuse issues, the Stark Law, joint ventures, purchase and sale of physician practices, employment and recruitment agreements, establishment of ambulatory surgery centers, imaging center and other ancillary service providers, managed care contracting and general business matters. In the corporate arena, Colvin has advised on mergers, acquisition, and dispositions; owner/shareholder relationships; commercial real estate and business organization; and succession planning.
“We are very excited for Adam to join our healthcare practice group,” said David Grauer, head of Squire Sanders’ Healthcare Practice Group. “His talent and extensive healthcare experience will create new opportunities and will add to the level of service we can provide our clients in Cincinnati, throughout Ohio, and across the country.”
Squire Sanders is recognized among the top 10 healthcare law practices by the American Health Lawyers Association. Additionally, the Healthcare Practice Group was highly ranked in Chambers USA 2013, listed in Tier 1 by US News & World Report for its annual “Best Law Firms” rankings, and awarded the International Law Office (ILO) Client Choice Award.
Admitted to practice in Ohio, Colvin earned his J.D. from the University of California, Los Angeles School of Law in 2003. He graduated cum laude from Harvard University with a Bachelor of Arts. In 2012, Colvin was named one of the Best Lawyers in America in Healthcare and recognized as an Ohio Rising Star by Law & Politics Media, Inc. Colvin comes to Squire Sanders from Katz Teller.
“I am delighted to become a part of Squire Sanders’ preeminent healthcare practice,” said Colvin. “I look forward to working with a strong set of experienced lawyers and to serving many of the industry’s leading clients across Squire Sanders’ global platform.”
